References
- Ramrattan RS, Wolfs RC, Panda-Jones, et al. Prevalence and causes of visual field loss in the elderly and associations with impairment in daily functioning; the Rotterdam study. Arch Ophthalmol 2001;119:1788–1794.
- Hong T, Mitchell P, Burlutsky G, et al. Visual impairment and the incidence of falls and fractures among older people; longitudinal findings from the Blue Mountains Eye study. Invest Ophthalmol Vis Sci 2014;55:7589–7593.
- Medeiros FA, Gracitelli CP, Boer ER, et al. Longitudinal changes in quality of life and rates of progressive visual field loss in glaucoma patients. Ophthalmology 2015;122:293–301.
- Bourne RA, Stevens GA, White RA, et al. Causes of vision loss worldwide, 1990–2010: a systematic analysis. Lancet 2013;1:339–349.
- Prince MJ, Wu F, Yanfei G, et al. The burden of disease in older people and implications on health policy and practice. Lancet 2015;385:549–562
- Frick KD, Kymes SM, Lee PP, et al., on behalf of The Vancouver Economic Burden of Vision Loss Group. The cost of visual impairment: purposes, perspectives, and guidance. Invest Ophthalmol Vis Sci 2010;51:1801–1805.
- Köberlein J, Beifus K, Schaffert C, et al. The economic burden of visual impairment and blindness: a systematic review. BMJ Open 2013;3:e003471.
- Eckert KA, Carter MJ, Lansingh VC, et al. A simple method for estimating the economic cost of productivity loss due to blindness and moderate to severe visual impairment. Ophthalmic Epidemiol 2015;22:349–355.
- Smith TST, Frick KD, Holden BA, et al. Potential lost productivity resulting from the global burden of uncorrected refractive error. Bull World Health Organ 2009;87:431–437.
- Bourne RRA, Jonas JB, Flaxman SR, et al. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe:1990–2010. Br J Ophthalmol 2014;98:629–638.
- RNIB website (2016). Retrieved from: www.rnib.org.uk/knowledge-and-research-hub/key-information-and-statistics
- U.S. disability statistics (2016). Retrieved from: www.disabilitystatistics.org/reports/acs.cfm?statistic=2
- Stevens GA, White RA, Flaxman SR, et al., on behalf of the Vision Loss Expert Group. Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990–2010. Ophthalmology 2013;120:2377–2384
- Global vision database (2016). Retrieved from: www.globalvisiondata.org
- Nord E. Disability weights in the Global Burden of Disease 2010: unclear meaning and overstatement of international agreement. Health Policy 2013;111:99–104.
- Taylor HR, Jonas JB, Keeffe J, et al. Disability weights for vision disorders in Global Burden of Disease study. Lancet 2013;381(9860):23.
- WHO methods and data sources for Global Burden of Disease estimates 2000–2011. Available from: http://www.who.int/healthinfo/statistics/GlobalDALYmethods_2000_2011.pdf
- Meads C, Hyde C. What is the cost of blindness? Br J Ophthalmol 2003;87:1201–1204.
- Roberts CB, Hiratsuka Y, Yamada M, et al. Economic cost of visual impairment in Japan. Arch Ophthalmol 2010;128:766–771.
- Cruess AF, Gordon KD, Bellan L, et al. The cost of vision loss in Canada. 2. Results. Can J Ophthalmol 2011;46:315–318.
- Rein DB, Zhang P, Wirth KE, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol 2006;124:1754–1760. Erratum in: Arch Ophthalmol 2007;125:1304.
- Eurostat database. Accessed 8 August 2016 from: http://ec.europa.eu/eurostat/data/database
- Jönsson B. Revealing the cost of type II diabetes in Europe. Diabetologia 2002;45:S5–12.